novartis - dofaq.co
New, serious safety risk related to MorphoSys' cancer drug complicates, potentially threatens, Novartis acquisition
STAT - 28 Apr 2024
New, serious safety risk related to MorphoSys' cancer drug complicates, potentially threatens, Novartis acquisition ...
Morphosys says takeover by Novartis on course after report of drug safety concern
Reuters - 29 Apr 2024
Morphosys says takeover by Novartis on course after report of drug safety concern ...
Safety Concerns with MorphoSys’ Blood Cancer Drug Could Mar $2.9B Novartis Buy: STAT
BioSpace - 29 Apr 2024
Safety Concerns with MorphoSys’ Blood Cancer Drug Could Mar $2.9B Novartis Buy: STAT ...
Novartis pays PeptiDream $180M as radiopharma big bang continues
Fierce Biotech - 30 Apr 2024
Novartis pays PeptiDream $180M as radiopharma big bang continues ...
MorphoSys AG Set for Novartis Acquisition - TipRanks.com
TipRanks - 29 Apr 2024
MorphoSys AG Set for Novartis Acquisition - TipRanks.com ...
Drugmaker Novartis climbs after guidance rise on sales of blockbuster drugs
CNBC - 23 Apr 2024
Drugmaker Novartis climbs after guidance rise on sales of blockbuster drugs ...
Novartis to cut 680 jobs in product development
Reuters - 09 Apr 2024
Novartis to cut 680 jobs in product development ...
Novartis, Neurocrine-Takeda, Enhertu—Fierce Pharma Asia
FiercePharma - 26 Apr 2024
Novartis, Neurocrine-Takeda, Enhertu—Fierce Pharma Asia ...
Alexion and Novartis/Genentech start UPC's first ever biosimilar disputes
IAM - 24 Apr 2024
Alexion and Novartis/Genentech start UPC's first ever biosimilar disputes ...
Research and development
Novartis - 08 Feb 2024
Research and development ...
Novartis Ag (NVS) Q1 2024 Earnings Call Transcript
The Motley Fool - 23 Apr 2024
Novartis Ag (NVS) Q1 2024 Earnings Call Transcript ...
Deciphex partners with Novartis for AI drug research
SiliconRepublic.com - 29 Apr 2024
Deciphex partners with Novartis for AI drug research ...
Novartis accused of promoting asthma drug for preterm labor despite brain risk
Reuters - 23 Apr 2024
Novartis accused of promoting asthma drug for preterm labor despite brain risk ...
Novartis dials up 2024 sales outlook, preps for key expansions of 3 cancer drugs
FiercePharma - 23 Apr 2024
Novartis dials up 2024 sales outlook, preps for key expansions of 3 cancer drugs ...
Parental leave
Novartis - 08 Feb 2024
Parental leave ...
Novartis raises guidance after beating Q1 expectations
Reuters - 23 Apr 2024
Novartis raises guidance after beating Q1 expectations ...
Novartis 'actively' reviewing relationships with Chinese contractors amid US biosecurity crackdown: CFO
FiercePharma - 23 Apr 2024
Novartis 'actively' reviewing relationships with Chinese contractors amid US biosecurity crackdown: CFO ...
Animal Research
Novartis - 31 Jan 2024
Animal Research ...
Novartis nominates ex-BMS chief Giovanni Caforio as its next chair
FiercePharma - 23 Apr 2024
Novartis nominates ex-BMS chief Giovanni Caforio as its next chair ...